Therefore, the aim of the aforementioned study was to develop and validate predictive radiomics models and nomogram models that can serve as reliable auxiliary tools for predicting BM in patients with ALK-positive lung adenocarcinoma, thereby providing valuable insights to improved patient management and treatment decision-making. This evidence concerns the gene ALK and lung adenocarcinoma.